The Natalie M. LaPrade Maryland Medical Cannabis Commission develops policies, procedures and regulations to implement programs that ensure medical cannabis is available to qualifying patients in a safe and effective manner. The Commission oversees all licensing, registration, inspection and testing measures pertaining to Maryland’s medical cannabis program and provides relevant program information to patients, physicians, growers, dispensers, processors, testing laboratories and caregivers.
Preliminary Industry Ownership
35% Racial and Ethnic Diversity Participation
57% Minority Participation Including
Preliminary Industry Employee
58% Racial and Ethnic Diversity Participation
75% Minority Participation Including
The Commission recognizes that these
numbers will change as all companies become licensed.
The MMCC is
releasing preliminary demographic data on ownership and employee participation
in the emerging medical cannabis industry.
I am encouraged by this preliminary data and I must emphasize preliminary, which shows that the
Commission is on the right path to achieving a diverse group of industry participants. The medical cannabis industry is charged with
making new and innovative medicine to help alleviate the pain and suffering of
qualifying patients, including sick children.
The Commission is dedicated to creating a world class program to support this mission, and believes that politics and misleading narratives should be kept out of the process.
was obtained by surveying the current pre-approved applicants. Based on COMAR,
on June 1 of each year, each licensee will be required to submit a report to
the Commission regarding the licensee’s minority owners and employees.
facts are that the Commission is making tremendous progress in implementing
this program; we have issued 15 pre-approvals to companies to grow medical
cannabis, 15 pre-approvals to companies to process medical cannabis, and 102
pre-approvals to companies to dispense medical cannabis. The program is moving
forward quickly with background and financial due diligence investigations
being conducted to begin industry operations.
Commission is aware and believes that diversity is an essential element in
making the medical cannabis program a success, and will continue to track this important
demographic data. As we measure the
industry’s progress, the Commission recognizes that corporate structures may
change for each entity, while always striving for inclusiveness and equal
opportunity. We still have work to do
and look forward to utilizing a diversity consultant.
As we enter
the operational phase of Maryland’s medical cannabis industry, I remain passionate
about the quality of the program, and reject additional legislation that would
disrupt the current progress that is being made in the final phase of this
Chairman of the Maryland Medical
Please click here for the breakdown of the data.
IMPORTANT INFORMATION FOR PROSPECTIVE MEDICAL CANNABIS PATIENTS:
While progress is being made, there is NO legal medical cannabis available to patients in Maryland. Please read the information below:
- Pre-Awards for Grower, Processor and Dispensaries have been announced, however, no actual final licenses to grow, process or dispense medical cannabis have been issued. The pre-approved entities are currently working through Stage Two of the licensing process, which includes extensive background investigations and regulatory requirements.
- This means there is no legal medical cannabis available to patients in the State of Maryland; written certifications for medical cannabis from physicians are not yet
valid in the State of Maryland.
- NO patient identification cards are being issued at this time. The only legal and valid ID cards will be issued by the Commission.
- These cards can only be obtained through the Patient Registry, which will open during the first quarter of 2017.
As a reminder, the process for obtaining legal medical cannabis, once available in the State, can be found here.
- Patients must first register as a qualifying patient on this website when the Patient Registry opens during the first quarter of 2017. The Patient Registry is not yet open.